4 days ago
Hyderābād, IndiaSenior
Responsibilities
- Configure and customize Planisware modules, workflows, forms, business rules, calculations, and project portfolio management capabilities.
- Develop and maintain integrations between Planisware and enterprise platforms including SAP, Anaplan, Autodesk Construction Cloud, Enterprise Data Fabric, and S3 data repositories.
- Support data migration, validation, reconciliation, imports, exports, transformations, and configuration migration across environments.
- Develop dashboards, portfolio reports, KPIs, forecasting, cost tracking, and executive reporting solutions.
- Perform unit, integration, regression, and end-to-end testing and support UAT planning and defect resolution.
- Participate in sprint planning, backlog refinement, release deployments, hypercare, and technical documentation.
- Provide Level 2/Level 3 application support, troubleshoot incidents, analyze root causes, and implement preventive measures.
- Ensure compliance with enterprise security, validation, change management, data quality, and governance processes.
Requirements
- Bachelor’s degree in computer science, Information Systems, Engineering, or a related field.
- At least 5 years of enterprise application development experience.
- At least 2 years of experience with Planisware Enterprise or another Project Portfolio Management platform.
- Strong understanding of project portfolio management, cost management, forecasting, resource management, financial reporting, and project governance.
- Experience with REST APIs, ETL processes, enterprise integrations, strong SQL, and data analysis.
- Preferred experience with Planisware configuration and development; integrations with SAP, Anaplan, Autodesk Construction Cloud, or enterprise data platforms; Databricks; Azure or AWS cloud services; and data pipelines.
- Preferred understanding of Engineering project delivery, capital project management, GxP-controlled environments, validation practices, and global enterprise application support.
About Amgen
Amgen is a public biotechnology company that discovers, develops, manufactures, and sells biologic and biosimilar therapeutics for patients with serious diseases. Its portfolio and pipeline span oncology, cardiovascular disease, osteoporosis, inflammation, and rare diseases, marketed globally through direct sales and partnerships. Founded in 1980 and headquartered in Thousand Oaks, California (NASDAQ: AMGN), Amgen is a component of the Dow Jones Industrial Average and completed the acquisition of Horizon Therapeutics in 2023.